Published Online:

National News Roundup

Article Tools
  • PrintPrinter-Friendly
  • EmailEmail Article
  • ReprintReprints
  • CommentsComments

Drug Company Warns Parents About Abuse of Ritalin

The company that produces Ritalin, a drug commonly prescribed to treat attention-deficit disorder, has launched a national education campaign to combat abuse of the medication.

Recent news reports have highlighted abuse of Ritalin, a brand-name for the stimulant methylphenidate, by children for whom the drug has not been prescribed.

Ciba Pharmaceuticals, a division of the Tarrytown, N.Y.-based Ciba-Geigy Corp., is warning parents to read about ADD and Ritalin and alert their children to the possible symptoms of Ritalin abuse, such as anxiety, lack of appetite, and breathing difficulties.

Web Only

Notice: We recently upgraded our comments. (Learn more here.) If you are logged in as a subscriber or registered user and already have a Display Name on edweek.org, you can post comments. If you do not already have a Display Name, please create one here.
Ground Rules for Posting
We encourage lively debate, but please be respectful of others. Profanity and personal attacks are prohibited. By commenting, you are agreeing to abide by our user agreement.
All comments are public.

Back to Top Back to Top

Most Popular Stories

Viewed

Emailed

Recommended

Commented